Physician profile
Ankit Mehta
NPI 1487810792
$54,712.04
in general payments reported to CMS, 2019-2025
15 companies · $33K in 2025
The $33K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,644 · 2021: $59.04 · 2022: $1,772 · 2023: $1,346 · 2024: $9,499 · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $42K · Food and Beverage: $1,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $42,459.67 |
| Food and Beverage | $1,777.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Expanding Innovations, INC. | $38,248.00 | 2023-2025 | X-Pac |
| Globus Medical, INC. | $9,375.00 | 2019-2025 | Hedron |
| Icotec Medical INC. | $3,829.68 | 2025 | Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm |
| Alphatec Spine, INC | $1,428.00 | 2022 | |
| Medical Device Business Services, INC. | $540.05 | 2021-2024 | Velys, Fibergraft Bg Morsels, Teligen |
| Carlsmed, INC. | $360.24 | 2025 | Aprevo |
| Carbofix Spine INC | $302.07 | 2021-2025 | |
| Depuy Synthes Sales INC. | $163.86 | 2024-2025 | Teligen, Velys |
| Sanara Medtech INC. | $114.07 | 2025 | Celleraterx |
| Aesculap, INC. | $91.84 | 2022 | |
| Cardiva Medical, INC. | $84.84 | 2022 | |
| Intrinsic Therapeutics | $80.12 | 2022 | |
| Nuvasive, INC. | $51.02 | 2019 | |
| Providence Medical Technology, INC. | $34.26 | 2019 | |
| Arbor Pharmaceuticals, INC. | $8.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$87,293.70 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.